Aehr Test Systems Reports 142% Revenue Growth, Faces Ongoing Profitability and Cash Challenges

Aehr Test Systems (NASDAQ: AEHR) has reported its financial results for the third quarter ended February 28, 2025. The company's performance showcases both positive growth and several challenges reflected in its income statement.

Key Highlights from the Income Statement:

• Total Revenue: $18.3 million in Q3 2025, a 142% increase from $7.6 million in Q3 2024, largely driven by a significant increase in product shipments.
• Product Revenue: $16.7 million in Q3 2025, a 148% increase from $6.7 million in Q3 2024.
• Service Revenue: Increased to $1.6 million, a 95% rise compared to $833,000 in Q3 2024.
• Net Loss: Reported at $643,000 in Q3 2025, compared to a net loss of $1.5 million in Q3 2024.
• Gross Profit: Rose to $7.2 million, up from $3.2 million year over year, despite a decrease in gross margin from 41.7% to 39.2% due to amortization of intangible assets.
• Operating Expenses: Totaled $8.3 million, increasing from $5.2 million due to higher research and development as well as selling, general, and administrative costs.
• Research and Development Expenses: Increased by 47% Q3 2025 to $3.1 million, driven by severance and recruitment fees.
• Cash and Cash Equivalents: Decreased to $31.4 million from $47.7 million a year earlier.

Positive Aspects:

• Significant revenue growth demonstrates strong demand for Aehr's semiconductor testing products, particularly in the AI and power semiconductor markets.
• The successful acquisition of Incal Technology has diversified product offerings and contributed substantially to revenue growth in package parts burn-in solutions.
• Higher gross profit reflects successful operational execution despite margin pressures.

Negative Aspects:

• Net loss persists, indicating challenges in profitability despite revenue growth.
• Reduction in cash balances indicates high spending, primarily for the Incal acquisition, impacting liquidity.
• Ongoing legal proceedings may pose risks and uncertainties impacting operational focus and costs.

In summary, while Aehr Test Systems (NASDAQ: AEHR) shows promising revenue growth and successful strategic moves like the Incal acquisition, it faces challenges regarding profitability and cash management amidst rising operational costs and legal contingencies.